📰 John Bluth News
Page 2 - John Bluth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Bluth. Real-time updates on events, politics, business and more.
August 4, 2023
RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation...
August 4, 2023
Operator: Good morning and welcome to the BioCryst Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference to Mr.
August 3, 2023
BCRX earnings call for the period ending June 30, 2023.
July 20, 2023
RESEARCH TRIANGLE PARK, N.C., July 20, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
July 19, 2023
RESEARCH TRIANGLE PARK, N.C., July 19, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered into a collaboration with Er-Kim Pharmaceuticals to commercialize ORLADEYO® (berotralstat) in Turkey. “We continue our mission to make ORLADEYO available to as many patients living with hereditary angioedema around the world as possible by partnering with companies that have deep expertise in commercializing rare disease therapies. We a...
June 6, 2023
RESEARCH TRIANGLE PARK, N.C., June 06, 2023 -- BioCryst Pharmaceuticals, Inc. today announced that the compensation committee of BioCryst’s board of directors granted 11 newly-hired... | June 6, 2023
May 22, 2023
RESEARCH TRIANGLE PARK, N.C., May 22, 2023 -- BioCryst Pharmaceuticals, Inc. today announced that the Public Health Institute of Chile has granted marketing authorization for oral, once-daily... | May 22, 2023
May 3, 2023
BCRX earnings call for the period ending March 31, 2023.
April 27, 2023
RESEARCH TRIANGLE PARK, N.C., April 27, 2023 -- BioCryst Pharmaceuticals, Inc. today announced new data from the APeX-S clinical trial, which evaluated oral, once-daily ORLADEYO® for the... | April 27, 2023
March 29, 2023
RESEARCH TRIANGLE PARK, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today acknowledged the many contributions...